278 related articles for article (PubMed ID: 20646934)
21. Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin.
Sesardic D; Prior C; Daas A; Buchheit KH;
Pharmeuropa Bio; 2003 Jul; 2003(1):5-21. PubMed ID: 14563306
[TBL] [Abstract][Full Text] [Related]
22. Collaborative assay of a proposed international standard for tetanus toxoid (adsorbed).
van Ramshorst JD; Sundaresan TK
Bull World Health Organ; 1972; 46(1):53-66. PubMed ID: 4537335
[TBL] [Abstract][Full Text] [Related]
23. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
[TBL] [Abstract][Full Text] [Related]
24. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
Buchheit KH; Daas A; Stalder J
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
[TBL] [Abstract][Full Text] [Related]
25. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
26. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2).
Winsnes R; Sesardic D; Daas A; Behr-Gross ME
Pharmeuropa Bio; 2006 Nov; 2006(1):73-88. PubMed ID: 17270133
[TBL] [Abstract][Full Text] [Related]
27. Collaborative study for the establishment of the third international standard for nystatin.
Rautmann G; Charton E; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):68-85. PubMed ID: 21144490
[TBL] [Abstract][Full Text] [Related]
28. Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human.
Stickings P; Rigsby P; Coombes L; von Hunolstein C; Ralli L; Pinto A; Sesardic D
Biologicals; 2013 Nov; 41(6):384-92. PubMed ID: 24011675
[TBL] [Abstract][Full Text] [Related]
29. A Vero cell method for potency testing of diphtheria vaccines.
Winsnes R; Sesardic D; Daas A; Rigsby P
Dev Biol (Basel); 2002; 111():141-8. PubMed ID: 12678233
[TBL] [Abstract][Full Text] [Related]
30. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
Van Ramshorst JD; Sundaresan TK; Outschoorn AS
Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
[TBL] [Abstract][Full Text] [Related]
31. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
Lensing HH; Behr-Gross ME; Daas A; Spieser JM
Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
[TBL] [Abstract][Full Text] [Related]
32. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
[TBL] [Abstract][Full Text] [Related]
33. Collaborative study for the establishment of erythropoietin BRP batch 3.
Behr-Gross ME; Daas A; Burns C; Bristow AF
Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
[TBL] [Abstract][Full Text] [Related]
34. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
[TBL] [Abstract][Full Text] [Related]
35. The 2nd International Standard for human granulocyte colony stimulating factor.
Wadhwa M; Bird C; Hamill M; Heath AB; Matejtschuk P; Thorpe R;
J Immunol Methods; 2011 Mar; 367(1-2):63-9. PubMed ID: 21334342
[TBL] [Abstract][Full Text] [Related]
36. Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):207-12. PubMed ID: 15572102
[TBL] [Abstract][Full Text] [Related]
37. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
[TBL] [Abstract][Full Text] [Related]
38. Collaborative study for the establishment of the second international standard for gramicidin.
Rautmann G; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):56-67. PubMed ID: 21144489
[TBL] [Abstract][Full Text] [Related]
39. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
[TBL] [Abstract][Full Text] [Related]
40. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
Terao E; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
